Patents/Assignees

XIGEN INFLAMMATION Ltd.

1 patent in portfolio

US11779628utility2023
Use of Cell-permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Various Diseases
0 cites